Metraipolis › archive › dc_43331e4d387c

Comparative risk of uveitis with Janus kinase inhibitors versus tumor necrosis factor inhibitors in ankylosing spondylitis and psoriatic diseases: a target… — Europe PMC PMID:41208989

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41208989
DOI
10.3389/fimmu.2025.1673970
License (as archived)
solo-consultazione
Archived
2026-11-09T01:45:32.483Z
SHA-256 of the archived text
1e00a389a9f0e7bb15be621a8b4407570be6dbe53bf6a0a282757a7cfa487702
Stable URL of this page
https://metraipolis.com/documento/dc_43331e4d387c

How to cite

Comparative risk of uveitis with Janus kinase inhibitors versus tumor necrosis factor inhibitors in ankylosing spondylitis and psoriatic diseases: a target… — Europe PMC PMID:41208989 — Europe PMC (en), https://europepmc.org/article/MED/41208989 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_43331e4d387c (Metraipolis archive dc_43331e4d387c, sha256 1e00a389a9f0e7bb15be621a8b4407570be6dbe53bf6a0a282757a7cfa487702)
BibTeX
@misc{dc43331e4d387c,
  title = {Comparative risk of uveitis with Janus kinase inhibitors versus tumor necrosis factor inhibitors in ankylosing spondylitis and psoriatic diseases: a target… — Europe PMC PMID:41208989},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41208989},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_43331e4d387c; sha256 1e00a389a9f0e7bb15be621a8b4407570be6dbe53bf6a0a282757a7cfa487702},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41208989. Agents can read the archived copy with the MCP tool read_document.